← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2021Last known activity
Apr 16, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 6 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (9)
- NCT06808295Lead sponsorPhase 1Apr 16, 2024
- NCT06808295Sponsor investigatorPhase 1Apr 16, 2024
- NCT05728151Lead sponsorN/AFeb 12, 2023
- NCT05539924Lead sponsorPhase 3Sep 15, 2022
- NCT05539911Lead sponsorEarly Phase 1Sep 1, 2022
- NCT05069350Lead sponsorEarly Phase 1Sep 1, 2021
- NCT04859062Sponsor investigatorN/AAug 1, 2021
- NCT04859062Reponsible party - principal investigatorN/AAug 1, 2021
- NCT04859062Lead sponsorN/AAug 1, 2021
Details
- Last known activity
- Apr 16, 2024